CFTR and cystic fibrosis: The most common mutation accountable for the onset of CF is the deletion of a phenylalanine at position 508 (F508del) within the nucleotide‐binding domain 1 (NBD1), which causes misfolding and retention of the CFTR in the ER with consequent premature degradation.